- Main event, leadership changes, market impact, financial shifts, or expert insights.
- Saylor suggests Bitcoin purchase amid Apple’s financial challenge.
- Bitcoin’s value surged following Saylor’s recommendation.

Michael Saylor’s suggestion for Apple to invest in Bitcoin underscores ongoing debates about optimal asset allocation strategies amidst corporate Treasury management shifts.
Michael Saylor publicly advised Apple to consider investing in Bitcoin. His statement came via a tweet expressing dissatisfaction with Apple’s $110 billion stock buyback program.
Apple hasn’t publicly addressed Saylor’s suggestion.
The recommendation comes as Apple’s share price falls 17% since early 2025, contrasting Bitcoin’s over 17% increase in value. Bitcoin’s market reaction was swift, with a 3.2% price rise following Saylor’s comments.
Bitcoin price reached $69,450 post-Saylor’s Tweet, indicating potential optimism among traders. Speculation surrounds what a major tech company’s move towards Bitcoin would signify for the market landscape.
Saylor’s stance resonates, as past corporate Bitcoin adoptions prompted shareholder and market gains. Such actions by firms like MicroStrategy and GameStop illustrate Bitcoin’s burgeoning role in corporate strategies.
Potential implications include bolstering Bitcoin’s presence in corporate treasuries, with historical precedents showing substantial Bitcoin integration can uplift company shares and market sentiment. Current frameworks don’t indicate Apple is pursuing this path.
“Apple should buy Bitcoin. The Apple buyback is not working right now.” — Michael Saylor, Executive Chairman, MicroStrategy
For further discussions on market reactions to such recommendations, you can refer to Jim Cramer’s insights on investment strategies.
Disclaimer: The content on The CCPress is provided for informational purposes only and should not be considered financial or investment advice. Cryptocurrency investments carry inherent risks. Please consult a qualified financial advisor before making any investment decisions. |